Tau as a potential novel therapeutic target in ischemic stroke

Journal of Cellular Biochemistry

Volumn 109, Issue 1, 2010, Pages 26-29

  Zheng, Guo Qing ^a   Wang, Xiu Min ^a   Wang, Yan ^a   Wang, Xiao Tong ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Ischemic stroke; Tau proteins; Therapeutic target

Indexed keywords

TAU PROTEIN;

ALZHEIMER DISEASE; CEREBROVASCULAR ACCIDENT; GLIA; HUMAN; MICROTUBULE; NERVE FIBER; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; PROTEIN TARGETING; REPERFUSION; REVIEW;

ANIMALS; HUMANS; MICROTUBULES; PHOSPHORYLATION; REPERFUSION INJURY; STROKE; TAU PROTEINS;

EID: 73849111401     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22408     Document Type: Review

References (27)

1. Andreadis A, Brown WM, Kosik KS. 1992. Structure and novel exons of the human tau gene. Biochemistry 31:10626-10633.
2. Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM. 1993. Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule binding. Neuron 10:1089-1099.
3. Burkhart KK, Beard DC, Lehman RA, Billingsley ML. 1998. Alterations in tau phosphorylation in rat and human neocortical brain slices following hypoxia and glucose deprivation. Exp Neurol 154:464-472.
4. Dewar D, Dawson D. 1995. Tau protein is altered by focal cerebral ischaemia in the rat: An immunohistochemical and immunoblotting study. Brain Res 684:70-78.
5. Donnan GA, Fisher M, Macleod M, Davis M. 2008. Stroke. Lancet 371:1612-1623.
6. Feigin VL. 2005. Stroke epidemiology in the developing world. Lancet 365:2160-2161.
7. Geddes JW, Schwab C, Craddock S, Wilson JL, Pettigrew LC. 1994. Alterations in tau immunostaining in the rat hippocampus following transient cerebral ischemia. J Cereb Blood Flow Metab 14:554-564.
8. Gendron TF, Petrucelli L. 2009. The role of tau in neurodegeneration. Mol Neurodegener 4:13.
9. Gordon-Krajcer W, Kozniewska E, Lazarewicz JW, Ksiezak-Reding H. 2007. Differential changes in phosphorylation of tau at PHF-1 and 12E8 epitopes during brain ischemia and reperfusion in gerbils. Neurochem Res 32:729-737.
10. Himmler A, Drechsel D, Kirschner MW, Martin DW, Jr. 1989. Tau consists of a set of proteins with repeated C-terminal microtubule-binding domains and variable N-terminal domains. Mol Cell Biol 9:1381-1388.
11. Iqbal K, Liu F, Gong CX, Alonso Adel C, Grundke-Iqbal I. 2009. Mechanisms of tau-induced neurodegeneration. Acta Neuropathol 118:53-69.
12. Irving EA, Nicoll J, Graham DI, Dewar D. 1996. Increased tau immunoreactivity in oligodendrocytes following human stroke and head injury. Neurosci Lett 213:189-192.
13. Irving EA, Yatsushiro K, McCulloch J, Dewar D. 1997. Rapid alteration of tau in oligodendrocytes after focal ischemic injury in the rat: Involvement of free radicals. J Cereb Blood Flow Metab 17:612-622.
14. Kanemaru K, Takio K, Miura R, Titani K, Ihara Y. 1992. Fetal-type phosphorylation of the tau in paired helical filaments. J Neurochem 58:1667-1675.
15. Liao G, Zhou M, Cheung S, Galeano J, Nguyen N, Baudry M, Bi X. 2009. Reduced early hypoxic/ischemic brain damage is associated with increased GLT-1 levels in mice expressing mutant (P301L) human tau. Brain Res 1247:159-1570.
16. Mailliot C, Podevin-Dimster V, Rosenthal RE, Sergeant N, Delacourte A, Fiskum G, Buée L. 2000. Rapid tau protein dephosphorylation and differential rephosphorylation during cardiac arrest-induced cerebral ischemia and reperfusion. J Cereb Blood Flow Metab 20:543-549.
17. Mazanetz MP, Fischer PM. 2007. Untangling tau hyperphosphorylation in drug design for neurodegenerative diseases. Nat Rev Drug Discov 6:464-479.
18. Morioka M, Kawano T, Yano S, Kai Y, Tsuiki H, Yoshinaga Y, Matsumoto J, Maeda T, Hamada J, Yamamoto H, Fukunaga K, Kuratsu J. 2006. Hyperphosphorylation at serine 199/202 of tau factor in the gerbil hippocampus after transient forebrain ischemia. Biochem Biophys Res Commun 347:273-278.
19. Panagos PD. 2008. The approach to optimizing stroke care. Am J Emerg Med 26:808-816.
20. Pluta R. 2004. Alzheimer lesions after ischemia-reperfusion brain injury. Folia Neuropathol 42:181-186.
21. Shackelford DA, Nelson KE. 1996. Changes in phosphorylation of tau during ischemia and reperfusion in the rabbit spinal cord. J Neurochem 66:286-295.
22. Shackelford DA, Yeh RY. 1998. Dephosphorylation of tau during transient forebrain ischemia in the rat. Mol Chem Neuropathol 34:103-120.
23. Tashiro K, Hasegawa M, Ihara Y, Iwatsubo T. 1997. Somatodendritic localization of phosphorylated tau in neonatal and adult rat cerebral cortex. Neuroreport 8:2797-2801.
24. Uchihara T, Tsuchiya K, Kondo H, Hayama T, Ikeda K. 1995. Widespread appearance of Alz-50 immunoreactive neurons in the human brain with cerebral infarction. Stroke 26:2145-2148.
25. Uchihara T, Tsuchiya K, Nakamura A, Ikeda K. 2000. Appearance of tau-2 immunoreactivity in glial cells in human brain with cerebral infarction. Neurosci Lett 286:99-102.
26. Uchihara T, Nakamura A, Arai T, Ikeda K, Tsuchiya K. 2004. Microglial tau undergoes phosphorylation-independent modification after ischemia. Glia 45:180-187.
27. Wen Y, Yang S, Liu R, Simpkins JW. 2004. Transient cerebral ischemia induces site-specific hyperphosphorylation of tau protein. Brain Res 1022: 30-38.